{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:48:33Z","timestamp":1759366113294,"version":"build-2065373602"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14895-2","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:36:00Z","timestamp":1759228560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evolution of microsatellite instability testing in a population-based cohort of patients with colorectal cancer in France in the years leading up to official recommendations"],"prefix":"10.1186","volume":"25","author":[{"given":"Sarah","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Guittet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9phine","family":"Gardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Dejardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"unstructured":"FNMR I FNMR. 2024 [cited 2025 Feb 12]. Panorama des cancers en France \u2013 INCA 09\/24. Available from: https:\/\/fnmr.fr\/panorama-des-cancers-en-france-inca-09-24\/","key":"14895_CR1"},{"issue":"4","key":"14895_CR2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1200\/JCO.18.00283","volume":"37","author":"A Latham","year":"2019","unstructured":"Latham A, Srinivasan P, Kemel Y, Shia J, Bandlamudi C, Mandelker D, et al. Microsatellite instability is associated with the presence of Lynch syndrome Pan-Cancer. J Clin Oncol. 2019;37(4):286\u201395.","journal-title":"J Clin Oncol"},{"issue":"23","key":"14895_CR3","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9 T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, et al. Pembrolizumab in Microsatellite-Instability\u2013High advanced colorectal cancer. N Engl J Med. 2020;383(23):2207\u201318.","journal-title":"N Engl J Med"},{"issue":"21","key":"14895_CR4","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1056\/NEJMoa2402141","volume":"391","author":"T Andr\u00e9","year":"2024","unstructured":"Andr\u00e9 T, Elez E, Cutsem EV, Jensen LH, Bennouna J, Mendez G, et al. Nivolumab plus ipilimumab in Microsatellite-Instability\u2013High metastatic colorectal cancer. N Engl J Med. 2024;391(21):2014\u201326.","journal-title":"N Engl J Med"},{"issue":"10476","key":"14895_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0140-6736(24)02848-4","volume":"405","author":"T Andr\u00e9","year":"2025","unstructured":"Andr\u00e9 T, Elez E, Lenz HJ, Jensen LH, Touchefeu Y, Van Cutsem E, et al. Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial. Lancet. 2025;405(10476):383\u201395.","journal-title":"Lancet"},{"issue":"10","key":"14895_CR6","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","volume":"31","author":"G Argil\u00e9s","year":"2020","unstructured":"Argil\u00e9s G, Tabernero J, Labianca R, Hochhauser D, Salazar R, Iveson T, et al. Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol. 2020;31(10):1291\u2013305.","journal-title":"Ann Oncol"},{"issue":"7","key":"14895_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11864-015-0348-2","volume":"16","author":"H Kawakami","year":"2015","unstructured":"Kawakami H, Zaanan A, Sinicrope FA. MSI testing and its role in the management of colorectal cancer. Curr Treat Options Oncol. 2015;16(7):30.","journal-title":"Curr Treat Options Oncol"},{"issue":"9","key":"14895_CR8","doi-asserted-by":"publisher","first-page":"101983","DOI":"10.1016\/j.clinre.2022.101983","volume":"46","author":"C Flecchia","year":"2022","unstructured":"Flecchia C, Zaanan A, Lahlou W, Basile D, Broudin C, Gallois C, et al. MSI colorectal cancer, all you need to know. Clin Res Hepatol Gastroenterol. 2022;46(9):101983.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"4","key":"14895_CR9","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/jcm8040558","volume":"8","author":"J Eriksson","year":"2019","unstructured":"Eriksson J, Amonkar M, Al-Jassar G, Lambert J, Malmen\u00e4s M, Chase M, et al. Mismatch repair\/microsatellite instability testing practices among US physicians treating patients with advanced\/metastatic colorectal cancer. J Clin Med. 2019;8(4):558.","journal-title":"J Clin Med"},{"issue":"3","key":"14895_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.6004\/jnccn.2021.0012","volume":"19","author":"AB Benson","year":"2021","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, et al. Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(3):329\u201359.","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"14895_CR11","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1200\/JCO.22.02462","volume":"41","author":"P Vikas","year":"2023","unstructured":"Vikas P, Messersmith H, Compton C, Sholl L, Broaddus RR, Davis A, et al. Mismatch repair and microsatellite instability testing for immune checkpoint inhibitor therapy: ASCO endorsement of college of American pathologists guideline. J Clin Oncol. 2023;41(10):1943\u20138.","journal-title":"J Clin Oncol"},{"issue":"1","key":"14895_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","volume":"34","author":"A Cervantes","year":"2023","unstructured":"Cervantes A, Adam R, Rosell\u00f3 S, Arnold D, Normanno N, Ta\u00efeb J, et al. Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(1):10\u201332.","journal-title":"Ann Oncol"},{"issue":"8","key":"14895_CR13","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/annonc\/mdz116","volume":"30","author":"C Luchini","year":"2019","unstructured":"Luchini C, Bibeau F, Ligtenberg MJL, Singh N, Nottegar A, Bosse T, et al. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1\/PD-L1 expression and tumour mutational burden: a systematic review-based approach. Ann Oncol. 2019;30(8):1232\u201343.","journal-title":"Ann Oncol"},{"issue":"5","key":"14895_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/bjs.11902","volume":"108","author":"TT Sepp\u00e4l\u00e4","year":"2021","unstructured":"Sepp\u00e4l\u00e4 TT, Latchford A, Negoi I, Sampaio Soares A, Jimenez-Rodriguez R, S\u00e1nchez\u2010Guill\u00e9n L, et al. European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender. Br J Surg. 2021;108(5):484\u201398.","journal-title":"Br J Surg"},{"unstructured":"Publication INC. \u00c9valuation du statut MMR tumoral - Synth\u00e8se 2021 - Onco-Nouvelle-Aquitaine [Internet]. https:\/\/onco-nouvelle-aquitaine.fr\/. [cited 2025 Feb 12]. Available from: https:\/\/onco-nouvelle-aquitaine.fr\/evaluation-du-statut-mmr-tumoral-synthese-2021\/","key":"14895_CR15"},{"issue":"7","key":"14895_CR16","doi-asserted-by":"publisher","first-page":"e2419142","DOI":"10.1001\/jamanetworkopen.2024.19142","volume":"7","author":"S Sabbagh","year":"2024","unstructured":"Sabbagh S, Herr\u00e1n M, Hijazi A, Jabbal IS, Mohanna M, Dominguez B, et al. Biomarker testing disparities in metastatic colorectal cancer. JAMA Netw Open. 2024;7(7):e2419142.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"14895_CR17","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/ajco.13076","volume":"14","author":"L Mascarenhas","year":"2018","unstructured":"Mascarenhas L, Shanley S, Mitchell G, Spurdle AB, Macrae F, Pachter N, et al. Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providers. Asia Pac J Clin Oncol. 2018;14(6):417\u201325.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"4","key":"14895_CR18","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s12094-023-03309-z","volume":"26","author":"R Garcia-Carbonero","year":"2024","unstructured":"Garcia-Carbonero R, Gonz\u00e1lez Astorga B, Vidal Tocino R, Contreras Toledo D, Pericay C, Fern\u00e1ndez Montes A, et al. Real-world study on microsatellite instability and mismatch repair deficiency testing patterns among patients with metastatic colorectal cancer in Spain. Clin Transl Oncol. 2024;26(4):864\u201371.","journal-title":"Clin Transl Oncol"},{"issue":"11","key":"14895_CR19","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/jech-2011-200311","volume":"66","author":"C Pornet","year":"2012","unstructured":"Pornet C, Delpierre C, Dejardin O, Grosclaude P, Launay L, Guittet L, et al. Construction of an adaptable European transnational ecological deprivation index: the French version. J Epidemiol Community Health. 2012;66(11):982\u20139.","journal-title":"J Epidemiol Community Health"},{"key":"14895_CR20","doi-asserted-by":"publisher","first-page":"101026","DOI":"10.1016\/j.gore.2022.101026","volume":"42","author":"SS Kelkar","year":"2022","unstructured":"Kelkar SS, Prabhu VS, Zhang J, Corman S, Macahilig C, Rusibamayila N, et al. Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer that are non-microsatellite instability high (non-MSI-high) or mismatch repair proficient (pMMR) in the united States. Gynecol Oncol Rep. 2022;42:101026.","journal-title":"Gynecol Oncol Rep"},{"issue":"6","key":"14895_CR21","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1007\/s00404-024-07504-3","volume":"309","author":"SS Kelkar","year":"2024","unstructured":"Kelkar SS, Prabhu VS, Zhang J, Ogando YM, Roney K, Verma RP, et al. Real-world prevalence of microsatellite instability testing and related status in women with advanced endometrial cancer in Europe. Arch Gynecol Obstet. 2024;309(6):2833\u201341.","journal-title":"Arch Gynecol Obstet"},{"key":"14895_CR22","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jss.2023.11.011","volume":"295","author":"TP Hinshaw","year":"2024","unstructured":"Hinshaw TP, Fu Y, Irish WD, Parikh AA, Snyder RA. Racial differences in stage IV colorectal cancer molecular profiling and mutation rates. J Surg Res. 2024;295:763\u20139.","journal-title":"J Surg Res"},{"issue":"11","key":"14895_CR23","doi-asserted-by":"publisher","first-page":"e1118","DOI":"10.1093\/oncolo\/oyad244","volume":"28","author":"MA Lewis","year":"2023","unstructured":"Lewis MA, Stansfield L, Kelton JM, Lieu CH. Biomarker testing trends in patients with metastatic colorectal cancer who live in rural areas and urban clusters in the US. Oncologist. 2023;28(11):e1118\u201322.","journal-title":"Oncologist"},{"key":"14895_CR24","doi-asserted-by":"publisher","first-page":"v72","DOI":"10.1093\/annonc\/mdy151.255","volume":"29","author":"Y Liang","year":"2018","unstructured":"Liang Y, Wei C, Tsai J, Jeng Y, Chen K, Cheng A, et al. Treatment efficacy and survival analysis of extremely elderly (80 years of age or older) patients with metastatic colorectal cancer: single Institute retrospective study. Ann Oncol. 2018;29:v72.","journal-title":"Ann Oncol"},{"issue":"3","key":"14895_CR25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/his.14710","volume":"81","author":"M Swets","year":"2022","unstructured":"Swets M, Graham Martinez C, van Vliet S, van Tilburg A, Gelderblom H, Marijnen CAM, et al. Microsatellite instability in rectal cancer: what does it mean? A study of two randomized trials and a systematic review of the literature. Histopathology. 2022;81(3):352\u201362.","journal-title":"Histopathology"},{"issue":"2","key":"14895_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/01.sla.0000080823.38569.b0","volume":"238","author":"J Engel","year":"2003","unstructured":"Engel J, Kerr J, Schlesinger-Raab A, Eckel R, Sauer H, H\u00f6lzel D. Quality of life in rectal cancer patients. Ann Surg. 2003;238(2):203\u201313.","journal-title":"Ann Surg"},{"issue":"25","key":"14895_CR27","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","volume":"386","author":"A Cercek","year":"2022","unstructured":"Cercek A, Lumish M, Sinopoli J, Weiss J, Shia J, Lamendola-Essel M, et al. PD-1 Blockade in mismatch Repair\u2013Deficient, locally advanced rectal cancer. N Engl J Med. 2022;386(25):2363\u201376.","journal-title":"N Engl J Med"},{"issue":"4","key":"14895_CR28","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1053\/gast.2001.28585","volume":"121","author":"A Duval","year":"2001","unstructured":"Duval A, Iacopetta B, Thorstensen L, Meling GI, Lothe RA, Thuille B, et al. Gender difference for mismatch repair deficiency in human colorectal cancer. Gastroenterology. 2001;121(4):1026\u20137.","journal-title":"Gastroenterology"},{"issue":"1","key":"14895_CR29","first-page":"126","volume":"61","author":"ML Slattery","year":"2001","unstructured":"Slattery ML, Potter JD, Curtin K, Edwards S, Ma KN, Anderson K, et al. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res. 2001;61(1):126\u201330.","journal-title":"Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14895-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14895-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14895-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:29:52Z","timestamp":1759274992000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14895-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14895"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14895-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}},{"value":"This study is based on data from digestive calvados cancer registry which is part of French national cancer registry association (FRANCIM). All cancer registries in France have received the approval of the French regulatory authorities for the collection and analysis of medical data : the \u2018Comit\u00e9 Consultatif sur le Traitement de l\u2019Information en mati\u00e8re de Recherche dans le domaine de la Sant\u00e9\u2019 (ethics approval) and the \u2018Commission Nationale Informatique et Libert\u00e9s\u2019 (legal framework and data protection).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Internal review board statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1450"}}